Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.

Arzneimittel-Forschung

Volumn 60, Issue 6 a, 2010, Pages 362-372

  Geisser, Peter ^a   Banké Bochita, José ^b  

^a Vifor (International) Inc   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; FERRIC CARBOXYMALTOSE; FERRIC ION; MALTOSE; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; MALE; MIDDLE AGED; SAFETY;

ADOLESCENT; ADULT; ANEMIA, IRON-DEFICIENCY; BLOOD PRESSURE; BODY TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FERRIC COMPOUNDS; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MALTOSE; MIDDLE AGED; PLACEBOS; SAFETY;

MLCS; MLOWN;

EID: 77956857469     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296301     Document Type: Article

References (0)